Woburn, Mass.-based BioProcessors Corp. has secured an $18 million Series C round of funding as it continues to commercialize its platform for managing biotech and pharmaceutical cell research environments.
Boston’s HLM Venture Partners led the round. The six-year-old startup’s existing investors Oxford Bioscience Partners, also of Boston, and Cambridge, Mass.-based HealthCare Ventures joined new investor New Science Ventures of New York in the round, which brings BioProcessors’ total raised to $42 million since its 2000 inception.
